PTC Therapeutics
PTCT
#2741
Rank
ยฃ4.78 B
Marketcap
ยฃ57.68
Share price
-2.08%
Change (1 day)
67.34%
Change (1 year)

Earnings for PTC Therapeutics (PTCT)

Earnings in 2026 (TTM): -ยฃ0.18 Billion

According to PTC Therapeutics 's latest financial reports the company's current earnings are ยฃ0.82 Billion. In 2025 the company made an earning of ยฃ0.52 Billion, an increase over its 2024 earnings that were of -ยฃ0.28 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for PTC Therapeutics from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ0.18 Billion-133.28%
2025 ยฃ0.52 B-291.84%
2024 -ยฃ0.28 Billion-47.84%
2023 -ยฃ0.53 Billion18.49%
2022 -ยฃ0.45 Billion13.34%
2021 -ยฃ0.39 Billion28.64%
2020 -ยฃ0.31 Billion67.94%
2019 -ยฃ0.19 Billion87.28%
2018 -ยฃ96.19 Million64.95%
2017 -ยฃ58.32 Million-45.13%
2016 -ยฃ0.11 Billion-16.72%
2015 -ยฃ0.13 Billion72.64%
2014 -ยฃ73.92 Million90.89%
2013 -ยฃ38.73 Million96.58%
2012 -ยฃ19.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
ยฃ11.85 B-6,797.47%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
ยฃ3.80 B-2,247.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-ยฃ0.13 Billion-27.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
ยฃ18.37 M-110.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
-ยฃ0.11 Billion-40.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-ยฃ0.52 Billion 190.50%๐Ÿ‡บ๐Ÿ‡ธ USA